|
Real-time Estimate
Cboe BZX
14:43:56 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 0.4930 USD | +13.52% |
|
-7.61% | -61.90% |
Company Valuation: Pasithea Therapeutics Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 38.74 | 18.77 | 3.989 | 29.79 | 14.51 | - | - |
| Change | - | -51.55% | - | 646.69% | -51.28% | - | - |
| Enterprise Value (EV) | -14.22 | 18.77 | 3.989 | 29.79 | 14.51 | 14.51 | 14.51 |
| Change | - | 231.95% | - | 646.69% | -51.28% | 0% | 0% |
| P/E | - | - | -0.25x | - | - | - | - |
| PBR | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - |
| Capitalization / Revenue | 2,573x | 38.6x | - | - | - | - | - |
| EV / Revenue | -0x | 0x | - | - | - | - | - |
| EV / EBITDA | 0x | - | - | -0x | -0.55x | -0.43x | -0.33x |
| EV / EBIT | 0x | - | - | -0x | -0.55x | -0.43x | -0.33x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | - | - | -12.69 | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 0.0151 | 0.4866 | - | - | - | - | - |
| EBITDA 1 | -4.506 | - | - | -20.19 | -26.4 | -33.8 | -44.4 |
| EBIT 1 | -4.507 | - | - | -20.86 | -26.4 | -33.8 | -44.4 |
| Net income | - | - | -13.9 | - | - | - | - |
| Net Debt | -52.97 | - | - | - | - | - | - |
| Reference price 2 | 35.4000 | 12.8340 | 3.1500 | 1.2900 | 0.4343 | 0.4343 | 0.4343 |
| Nbr of stocks (in thousands) | 1,094 | 1,462 | 1,266 | 23,091 | 33,414 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/24/25 | 3/30/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 14.51M | ||
| 17.32x | 6.64x | 12.72x | 1.72% | 66.37B | ||
| 31.83x | 8.5x | 28.08x | 0.07% | 58.86B | ||
| 38.41x | 6.84x | 20.46x | 0.85% | 55.22B | ||
| 44.35x | 6.2x | 29.52x | -.--% | 47.21B | ||
| 33.62x | 3.22x | 13.9x | -.--% | 42.45B | ||
| 35.98x | 8.9x | 23.21x | 0.36% | 36.44B | ||
| -19.28x | 55.7x | -21.11x | -.--% | 35.19B | ||
| 41.59x | 8.02x | 26.91x | -.--% | 32.66B | ||
| -74.36x | 14.09x | -75.73x | -.--% | 26.73B | ||
| Average | 16.61x | 13.12x | 6.44x | 0.33% | 40B | |
| Weighted average by Cap. | 21.61x | 11.64x | 11.39x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- KTTA Stock
- Valuation Pasithea Therapeutics Corp.
Select your edition
All financial news and data tailored to specific country editions
















